Metabolic treatment: A potential breakthrough in diabetic heart disease
SGLT2i-drug induced hyperketonemia improved cardiac function for Type 2 diabetic patients with heart failure Heart disease is the leading cause of...
SGLT2i-drug induced hyperketonemia improved cardiac function for Type 2 diabetic patients with heart failure Heart disease is the leading cause of...
MUSC Health Florence Medical Center has spearheaded the introduction of an advanced aerosol delivery system – one that is now transforming how respiratory...
Scientists have identified protein tyrosine phosphatase delta (PTPRD) as a key regulator of liver metabolism, offering a potential new drug...
Pope Francis gestures as he appears at a window of the Agostino Gemelli Polyclinic in Rome on Sunday.Domenico StinellisPope Francis...
An endocrinologist explains the important role this hormone-producing gland plays in the body, along with common thyroid diseases, symptoms, and...
Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of a...